Lastest News


7 pharmaceutical companies at most to achieve KRW 1 trillion sales this year

There will be much more pharmaceutical companies with more than KRW 1 trillion sales this year. While there were only 3 pharmaceutical companies last year, it seems the number will get enlarged to 7 companies at most....

MOHW’s integrity increasing continuously last 3 years, from last to 10th to 5th

As the Ministry of Health and Welfare’s(MOHW) government office integrity ranking continuously went up, it reportedly jumped from the last to the 5th only in 3 years. Its grade stayed remained at Grade 3 for 2 years. ...

Government looking for companies to take ‘KRW 30 billion Initial Technology Venture Funds for the Health Care Industry’

The Ministry of Health and Welfare will create a fund of KRW 30 billion to energize ventures in the health care industry. The MOHW(Minister Neung-Hoo Park) had decided to make the ‘Initial Technology Venture Funds fo...

Samsung Biologics signs a contract manufacturing agreement of KRW 17.8 billion with U.S. pharma

Samsung Biologics announced conclusion of a contract manufacturing agreement with a U.S. pharmaceutical company on 21 February. The agreed payment is approximately KRW 17.8 billion(6.06% of recent sales), and the sta...

Celltrion Healthcare starts to expand business into the Latin America

Celltrion Healthcare has started the engine to enlarge its market share in the Latin American market by signing a distribution and sales agreement of ‘Truxima(generic name: rituximab),’ a biosimilar for the treatment ...

Kolmar Korea to bring an upheaval in pharma industry with acquisition of CJ HealthCare

Kolmar Korea, a global cosmetic ODM(Original Design Manufacturer) company and the top CMO(Contract Manufacturing Organization) in Korea, will acquire the pharmaceutical company under CJ Group, CJ HealthCare. The acqui...

Most incrementally modified drugs approved last year were antihypertensives with 7 products

Just like new drugs, incrementally modified drugs that are being developed by Korean pharmaceutical companies are also experiencing a drought as well. According to the Ministry of Food and Drug Safety, there were 11 ...

Rapid increase of bioequivalently proven medicines, what is the reason?

The number of medicines bioequivalently proven this year was 157 products, reportedly increased by 58%. The phenomenon was caused by the fact the Korean pharmaceutical companies have been active in developing generic...

Rapid increase of bioequivalently proven medicines, what is the reason?

The number of medicines bioequivalently proven this year was 157 products, reportedly increased by 58%. The phenomenon was caused by the fact the Korean pharmaceutical companies have been active in developing generic...

SCD Pharm signs total KRW 700 billion export agreement with U.S. Glenmark

Sam Chun Dang Pharm(CEO Jeon-Kyo Park, SCD Pharm) signed a export agreement of its generic eye drop with U.S. Glenmark on the 20th. The export agreement is the 2nd largest export agreement after the last KRW 400 billi...

Pharmaceutical industry caught two hares at once

While recording a huge growth both in quality and quantity with 32% increased employees only in 10 years, the Korean pharmaceutical industry was analyzed to have a bright future ahead as having increases in all the ca...

Celltrion proves equivalent effect on Remsima, Remicade and Humira

At the 2018 European Crohn’s and Colitis Organisastion(ECCO) held in Vienna, Austria, large clinical study results on Crohn’s disease patients were revealed. In these studies, the remission rate of each patient group...

Hanmi Pharm’s new oral anticancer drug ‘Oraxol starts global Phase III clinical trial

They will actively start the global Phase III clinical trial of Oraxol, an oral anticancer drug developed by Hanmi Pharm. A Hanmi Pharm’s partner, Athenex(Nasdaq: ATNX) announced that the company completed the Phase ...

Pouring generic approval of ‘Dexid Tab’ generics, will enlarge market of diabetic neuropathy therapies?

Dexid Tab, a diabetic neuropathy therapy, were reportedly referenced by more than 40 generic drugs to acquire approval. The market size of Dexid Tab is calculated at approximately KRW 10 billion, but it seems it will...

“Pharmacies with less than 5 employees must follow rules about minimum wage and retirement pension”

It was requested to definitely follow the minimum wage, holiday benefits and retirement pension not to cause any trouble in pharmacies with less than 5 employees. It was also stressed it would be important to fully u...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.